News

We are happy to announce that BÜHLMANN Laboratories AG has two new, attractive SARS-CoV-2 Antigen (Ag) rapid tests in its portfolio.

South Korea’s biotechnology firm Seegene (KQ096530) said Monday it developed the world’s first COVID-19 diagnostic variant test, capable of screening COVID-19 and identifying multiple mutant variations in a single reaction.

Herewith we would like to inform you that all three Seegene COVID-19 kits (Cat. # RP10243X; RV10248X; RV10259X) are capable of detecting the new UK and South Africa variant of SARS-CoV-2.

At their virtual booth, Seegene presented their complete solution for COIVD-19 diagnostics including new videos